In addition, NK cells have been found to mediate the clearance of CD8+ T cell-resistant tumors.6 Unfortunately, only about 20% of cancer patients respond to immunotherapies presumably due to inadequate immune activation.5,7,8. Here, CD8A is linked to cancer.